Cornerstone Capital Management Holdings’s Teva Pharmaceuticals TEVA Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-75,900	Closed	-$2.52M	–	1315
2017 Q2	$2.52M	Buy	75,900 +57,300	+308%	+$1.77M	0.02%	649
2017 Q1	$596K	Buy	+18,600	New	+$635K	﹤0.01%	1028
2014 Q1	–	Sell	-564,075	Closed	-$22.6M	–	1397
2013 Q4	$22.6M	Sell	564,075 -117,935	-17%	-$4.64M	0.26%	93
2013 Q3	$25.8M	Sell	682,010 -646,313	-49%	-$25.2M	0.31%	59
2013 Q2	$52.1M	Buy	+1,328,323	New	+$51.7M	0.64%	24

Other funds holding TEVA

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Cornerstone Capital Management Holdings's TEVA Position: Q3 2017 in Review

Cornerstone Capital Management Holdings sold out of Teva Pharmaceuticals (TEVA) in Q3 2017, closing a stake of 75,900 shares — an estimated $2.52M sold.

Cornerstone Capital Management Holdings first reported a position in TEVA in Q2 2013 and held it in 5 quarters. The position peaked at $52.1M in Q2 2013. 535 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

Cornerstone Capital Management Holdings reported no remaining Teva Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
Cornerstone Capital Management Holdings sold 75,900 Teva Pharmaceuticals shares in Q3 2017, an estimated $2.52M.
Cornerstone Capital Management Holdings first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 5 quarters.
Cornerstone Capital Management Holdings's Teva Pharmaceuticals position peaked at $52.1M in Q2 2013.
535 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q3 2017, filed 14 Nov 2017.